» Articles » PMID: 26970015

Kynurenine Pathway Metabolites and Enzymes Involved in Redox Reactions

Overview
Specialties Neurology
Pharmacology
Date 2016 Mar 13
PMID 26970015
Citations 63
Authors
Affiliations
Soon will be listed here.
Abstract

Oxido-reduction reactions are a fundamental part of the life due to support many vital biological processes as cellular respiration and glucose oxidation. In the redox reactions, one substance transfers one or more electrons to another substance. An important electron carrier is the coenzyme NAD, which is involved in many metabolic pathways. De novo biosynthesis of NAD is through the kynurenine pathway, the major route of tryptophan catabolism, which is sensitive to redox environment and produces metabolites with redox capacity, able to alter biological functions that are controlled by redox-responsive signaling pathways. Kynurenine pathway metabolites have been implicated in the physiology process and in the physiopathology of many diseases; processes that also share others factors as dysregulation of calcium homeostasis, mitochondrial dysfunction, oxidative stress, inflammation and cell death, which impact the redox environment. This review examines in detail the available evidence in which kynurenine pathway metabolites participate in redox reactions and their effect on cellular redox homeostasis, since the knowledge of the main factors and mechanisms that lead to cell death in many neurodegenative disorders and other pathologies, such as mitochondrial dysfunction, oxidative stress and kynurenines imbalance, will allow to develop therapies using them as targets. This article is part of the Special Issue entitled 'The Kynurenine Pathway in Health and Disease'.

Citing Articles

Early detection of feline chronic kidney disease via 3-hydroxykynurenine and machine learning.

Vanden Broecke E, Van Mulders L, De Paepe E, Paepe D, Daminet S, Vanhaecke L Sci Rep. 2025; 15(1):6875.

PMID: 40011503 PMC: 11865484. DOI: 10.1038/s41598-025-90019-x.


Plasma and Visceral Organ Kynurenine Metabolites Correlate in the Multiple Sclerosis Cuprizone Animal Model.

Polyak H, Galla Z, Rajda C, Monostori P, Klivenyi P, Vecsei L Int J Mol Sci. 2025; 26(3).

PMID: 39940744 PMC: 11817772. DOI: 10.3390/ijms26030976.


Preliminary analyses of tryptophan, kynurenine, and the kynurenine: Tryptophan ratio in plasma, as potential biomarkers for systemic chlamydial infections in koalas.

Chen C, Kimble B, Van Aggelen A, Fischer S, Flanagan C, Gillett A PLoS One. 2024; 19(12):e0314945.

PMID: 39700217 PMC: 11658483. DOI: 10.1371/journal.pone.0314945.


Redefining Roles: A Paradigm Shift in Tryptophan-Kynurenine Metabolism for Innovative Clinical Applications.

Tanaka M, Szabo A, Vecsei L Int J Mol Sci. 2024; 25(23).

PMID: 39684480 PMC: 11640972. DOI: 10.3390/ijms252312767.


Modulation of Brain Kynurenic Acid by N-Acetylcysteine Prevents Cognitive Impairment and Muscular Weakness Induced by Cisplatin in Female Rats.

Dorcas Aremu T, Ramirez Ortega D, Blanco Ayala T, Gonzalez Esquivel D, Pineda B, Perez de la Cruz G Cells. 2024; 13(23).

PMID: 39682737 PMC: 11640147. DOI: 10.3390/cells13231989.